CXCL1 and pulmonary fibrosis: The genetic Cxcl1 deletion or pharmaceutical inhibition of Cxcl1 binding to Cxcr2 by Reparixin ameliorated the exacerbation of pulmonary fibrosis induced by particulate matter [248].